NM_000507.4:c.*21C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000507.4(FBP1):​c.*21C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.504 in 1,603,824 control chromosomes in the GnomAD database, including 206,469 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 20119 hom., cov: 32)
Exomes 𝑓: 0.50 ( 186350 hom. )

Consequence

FBP1
NM_000507.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.05

Publications

17 publications found
Variant links:
Genes affected
FBP1 (HGNC:3606): (fructose-bisphosphatase 1) Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]
PCAT7 (HGNC:48824): (prostate cancer associated transcript 7)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-94603360-G-A is Benign according to our data. Variant chr9-94603360-G-A is described in ClinVar as [Benign]. Clinvar id is 256318.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBP1NM_000507.4 linkc.*21C>T 3_prime_UTR_variant Exon 7 of 7 ENST00000375326.9 NP_000498.2 P09467
FBP1NM_001127628.2 linkc.*21C>T 3_prime_UTR_variant Exon 8 of 8 NP_001121100.1 P09467Q2TU34
FBP1XM_006717005.5 linkc.*21C>T 3_prime_UTR_variant Exon 7 of 7 XP_006717068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBP1ENST00000375326.9 linkc.*21C>T 3_prime_UTR_variant Exon 7 of 7 1 NM_000507.4 ENSP00000364475.5 P09467

Frequencies

GnomAD3 genomes
AF:
0.512
AC:
77802
AN:
151822
Hom.:
20105
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.490
Gnomad AMI
AF:
0.673
Gnomad AMR
AF:
0.634
Gnomad ASJ
AF:
0.680
Gnomad EAS
AF:
0.413
Gnomad SAS
AF:
0.432
Gnomad FIN
AF:
0.418
Gnomad MID
AF:
0.541
Gnomad NFE
AF:
0.515
Gnomad OTH
AF:
0.541
GnomAD2 exomes
AF:
0.515
AC:
125573
AN:
243660
AF XY:
0.509
show subpopulations
Gnomad AFR exome
AF:
0.486
Gnomad AMR exome
AF:
0.697
Gnomad ASJ exome
AF:
0.658
Gnomad EAS exome
AF:
0.398
Gnomad FIN exome
AF:
0.426
Gnomad NFE exome
AF:
0.510
Gnomad OTH exome
AF:
0.526
GnomAD4 exome
AF:
0.503
AC:
730395
AN:
1451884
Hom.:
186350
Cov.:
30
AF XY:
0.501
AC XY:
362128
AN XY:
722176
show subpopulations
African (AFR)
AF:
0.495
AC:
16467
AN:
33270
American (AMR)
AF:
0.695
AC:
30661
AN:
44102
Ashkenazi Jewish (ASJ)
AF:
0.658
AC:
17099
AN:
25994
East Asian (EAS)
AF:
0.391
AC:
15428
AN:
39476
South Asian (SAS)
AF:
0.435
AC:
37144
AN:
85370
European-Finnish (FIN)
AF:
0.425
AC:
22621
AN:
53172
Middle Eastern (MID)
AF:
0.539
AC:
3004
AN:
5572
European-Non Finnish (NFE)
AF:
0.504
AC:
556662
AN:
1104912
Other (OTH)
AF:
0.522
AC:
31309
AN:
60016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
16939
33879
50818
67758
84697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16080
32160
48240
64320
80400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.512
AC:
77858
AN:
151940
Hom.:
20119
Cov.:
32
AF XY:
0.509
AC XY:
37766
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.490
AC:
20287
AN:
41442
American (AMR)
AF:
0.634
AC:
9674
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.680
AC:
2357
AN:
3464
East Asian (EAS)
AF:
0.413
AC:
2125
AN:
5146
South Asian (SAS)
AF:
0.432
AC:
2077
AN:
4804
European-Finnish (FIN)
AF:
0.418
AC:
4411
AN:
10558
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.515
AC:
35020
AN:
67960
Other (OTH)
AF:
0.540
AC:
1135
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1964
3928
5892
7856
9820
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
60273
Bravo
AF:
0.529
Asia WGS
AF:
0.433
AC:
1506
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fructose-biphosphatase deficiency Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.3
DANN
Benign
0.67
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9695; hg19: chr9-97365642; COSMIC: COSV64688882; COSMIC: COSV64688882; API